Cointime

Home / Blueprint Medicines / investors

Blueprint Medicines

company

Investors

Number of Lead Investors
Number of Investors
4
15
Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Partner Fund Management Yes Series C
Eight Roads Ventures Yes Series Unknown
Casdin Capital - Series C
Cowen Group - Series C
Fidelity Biosciences - Series C
Nextech Invest - Series C
Perceptive Advisors - Series C
RA Capital Management - Series C
Redmile Group - Series C
Sabby Capital - Series C
Tavistock Life Sciences - Series C
Third Rock Ventures - Series C
Wellington Management - Series C
Biotechnology Value Fund - Series B
F-Prime Capital - Series B
Cointime
İçerikler
Şirket.